The influence of APOE ε4 on the pTau interactome in sporadic Alzheimer’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
The influence of APOE ε4 on the pTau interactome in sporadic Alzheimer’s disease ; volume:147 ; number:1 ; day:21 ; month:5 ; year:2024 ; pages:1-19 ; date:6.2024
Acta neuropathologica ; 147, Heft 1 (21.5.2024), 1-19, 6.2024
- Urheber
-
Thierry, Manon
Ponce, Jackeline
Martà-Ariza, Mitchell
Askenazi, Manor
Faustin, Arline
Leitner, Dominique
Pires, Geoffrey
Kanshin, Evgeny
Drummond, Eleanor
Ueberheide, Beatrix
Wisniewski, Thomas
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00401-024-02744-8
- URN
-
urn:nbn:de:101:1-2407310957362.140783408502
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Thierry, Manon
- Ponce, Jackeline
- Martà-Ariza, Mitchell
- Askenazi, Manor
- Faustin, Arline
- Leitner, Dominique
- Pires, Geoffrey
- Kanshin, Evgeny
- Drummond, Eleanor
- Ueberheide, Beatrix
- Wisniewski, Thomas
- SpringerLink (Online service)
Ähnliche Objekte (12)
Serum proteomics reveal APOE-ε4-dependent and APOE-ε4-independent protein signatures in Alzheimer’s disease
Author Correction: Serum proteomics reveal APOE-ε4-dependent and APOE-ε4-independent protein signatures in Alzheimer’s disease
APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer’s disease
The genetic risk of Alzheimer’s disease beyond APOE ε4: systematic review of Alzheimer’s genetic risk scores
The relationship between complement factor C3, APOE ε4, amyloid and tau in Alzheimer’s disease
APOE ε4, Alzheimer’s disease neuropathology and sleep disturbance, in individuals with and without dementia
Effect of APOE ε4 genotype on amyloid-β and tau accumulation in Alzheimer’s disease
CSF biomarkers for Alzheimer's pathology and the effect size of APOE ε4
Evidence that an APOE ε4 'double whammy' increases risk for Alzheimer's disease
Correction: Short leukocyte telomeres predict 25-year Alzheimer’s disease incidence in non-APOE ε4-carriers
Brain APOE expression quantitative trait loci-based association study identified one susceptibility locus for Alzheimer’s disease by interacting with APOE ε4
Impact of APOE ε4 genotype on initial cognitive symptoms differs for Alzheimer’s and Lewy body neuropathology
Serum proteomics reveal APOE-ε4-dependent and APOE-ε4-independent protein signatures in Alzheimer’s disease
Author Correction: Serum proteomics reveal APOE-ε4-dependent and APOE-ε4-independent protein signatures in Alzheimer’s disease
APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer’s disease
The genetic risk of Alzheimer’s disease beyond APOE ε4: systematic review of Alzheimer’s genetic risk scores
The relationship between complement factor C3, APOE ε4, amyloid and tau in Alzheimer’s disease
APOE ε4, Alzheimer’s disease neuropathology and sleep disturbance, in individuals with and without dementia
Effect of APOE ε4 genotype on amyloid-β and tau accumulation in Alzheimer’s disease
CSF biomarkers for Alzheimer's pathology and the effect size of APOE ε4
Evidence that an APOE ε4 'double whammy' increases risk for Alzheimer's disease
Correction: Short leukocyte telomeres predict 25-year Alzheimer’s disease incidence in non-APOE ε4-carriers
Brain APOE expression quantitative trait loci-based association study identified one susceptibility locus for Alzheimer’s disease by interacting with APOE ε4
Impact of APOE ε4 genotype on initial cognitive symptoms differs for Alzheimer’s and Lewy body neuropathology
Serum proteomics reveal APOE-ε4-dependent and APOE-ε4-independent protein signatures in Alzheimer’s disease
Author Correction: Serum proteomics reveal APOE-ε4-dependent and APOE-ε4-independent protein signatures in Alzheimer’s disease
APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer’s disease
The genetic risk of Alzheimer’s disease beyond APOE ε4: systematic review of Alzheimer’s genetic risk scores
The relationship between complement factor C3, APOE ε4, amyloid and tau in Alzheimer’s disease
APOE ε4, Alzheimer’s disease neuropathology and sleep disturbance, in individuals with and without dementia
Effect of APOE ε4 genotype on amyloid-β and tau accumulation in Alzheimer’s disease
CSF biomarkers for Alzheimer's pathology and the effect size of APOE ε4
Evidence that an APOE ε4 'double whammy' increases risk for Alzheimer's disease
Correction: Short leukocyte telomeres predict 25-year Alzheimer’s disease incidence in non-APOE ε4-carriers
Brain APOE expression quantitative trait loci-based association study identified one susceptibility locus for Alzheimer’s disease by interacting with APOE ε4